A retrospective study of Aeromonas hydrophila infections at a university tertiary hospital in Saudi Arabia.

Reham Kaki
Author Information
  1. Reham Kaki: Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia. rmkaki@kau.edu.sa. ORCID

Abstract

BACKGROUND: Aeromonas hydrophila can cause a wide range of diseases and is mainly found in patients with underlying diseases. Globally the data on Aeromonas infections is limited, and no studies have been published about the situation in Saudi Arabia. The aim of this study was to investigate the risk factors, clinical presentation, treatment, and outcomes of Aeromonas infections in Saudi Arabia.
METHODS: A retrospective study was performed at a tertiary university hospital with 1000 beds in Jeddah, Saudi Arabia. All patients 14 years and older with Aeromonas-positive cultures between January 1, 2015, and December 31, 2022 were included. Patient information was extracted from the electronic health records, including patient demographics, comorbidities, presenting symptoms, source of infection, human immunodeficiency virus status, culture results and antimicrobial susceptibility, use of immunosuppressive medication, and 30-day mortality.
RESULTS: In total 24 patients were identified with Aeromonas hydrophila-positive cultures, 22 of which were males (91.7%), and most (75%) had hospital-acquired infections. The 30-day mortality was 20.8%. All Aeromonas cultures were susceptible to gentamicin, cefepime, and ciprofloxacin, while the majority were resistant to ceftazidime (83.3%) and meropenem (62.5%). The most common disease presentation was skin and soft tissue infection (33.3%), the most common clinical sign was fever (58.3%), and the most common symptom was abdominal pain (37.5%). Comorbidities were very common (median 3, range 1-7). Pitt bacteremia score (p < 0.001), Charlson weighted comorbidity index (p < 0.02), international normalized ratio (p < 0.005), and the number of comorbidity factors (p < 0.05) were all associated with 30-day mortality due to Aeromonas infection. The number of comorbidities had the best predictive value (83.3%) of 30-day mortality (p < 0.05, Odds ratio 3.253, 95% confidence interval: 1.088-9.729).
CONCLUSIONS: Aeromonas hydrophila is an important pathogen to consider in nosocomial infections. The number of comorbidities had the best predictive value of 30-day mortality. The susceptibility pattern of this organism indicates that, in Saudi Arabia, when an Aeromonas infection is suspected, treatment with quinolone along with other broad-spectrum antibiotics should be started until the culture and susceptibility results are known.

Keywords

References

  1. Janda JM, Abbott SL. The genus Aeromonas: taxonomy, pathogenicity, and infection. Clin Microbiol Rev. 2010;23:35–73. [DOI: 10.1128/CMR.00039-09]
  2. Igbinosa IH, Igumbor EU, Aghdasi F, Tom M, Okoh AI. Emerging Aeromonas species infections and their significance in public health. ScientificWorldJournal. 2012; 2012:625023.
  3. Senderovich Y, Ken-Dror S, Vainblat I, Blau D, Izhaki I, Halpern M. A molecular study on the prevalence and virulence potential of Aeromonas spp. recovered from patients suffering from diarrhea in Israel. PLoS ONE. 2012;7:e30070. [DOI: 10.1371/journal.pone.0030070]
  4. Parker JL, Shaw JG. Aeromonas spp. clinical microbiology and disease. J Infect. 2011;62:109–18. [DOI: 10.1016/j.jinf.2010.12.003]
  5. Figueras MJ, Beaz-Hidalgo R. In: Graf J, editor. Aeromonas infections in humans. Aeromonas UK: Caister Academic Press; 2015. pp. 65–108.
  6. Lobaton T, Hoffman I, Vermeire S, Ferrante M, Verhaegen J, Van Assche G. Aeromonas species: an opportunistic enteropathogen in patients with inflammatory bowel diseases? A single center cohort study. Inflamm Bowel Dis. 2015;21:71–8. [DOI: 10.1097/MIB.0000000000000247]
  7. Lamy B, Kodjo A, colBVH Study Group, Laurent F. Prospective nationwide study of Aeromonas infections in France. J Clin Microbiol. 2009;47:1234–7. [DOI: 10.1128/JCM.00155-09]
  8. von Graevenitz A. The role of Aeromonas in diarrhea: a review. Infection. 2007;35:59–64. [DOI: 10.1007/s15010-007-6243-4]
  9. Sinclair HA, Heney C, Sidjabat HE, George NM, Bergh H, Anuj SN, Nimmo GR, Paterson DL. Genotypic and phenotypic identification of aeromonas species and carbapenem resistance in Queensland, Australia. Pathology. 2015;47:S96. [DOI: 10.1097/01.PAT.0000461607.27019.d9]
  10. Sinclair HA, Heney C, Sidjabat HE, George NM, Bergh H, Anuj SN, Nimmo GR, Paterson DL. Genotypic and phenotypic identification of Aeromonas species and CphA-mediated carbapenem resistance in Queensland, Australia. Diagn Microbiol Infect Dis. 2016;85:98–101. [DOI: 10.1016/j.diagmicrobio.2016.02.005]
  11. CLSI. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria. Approved Guideline. Vol. M45-A2. PA, USA: The Clinical and Laboratory Standards Institute; 2010. 30, No. 18, Second edn. Wayne,.
  12. CLSI. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of infrequently isolated or fastidious Bacteria. Vol. M45. third edn. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2016.
  13. Ko WC, Lee HC, Chuang YC, Liu CC, Wu JJ. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia. J Infect. 2000;40:267–73. [DOI: 10.1053/jinf.2000.0654]
  14. Mandal J, Kumaravel S, Ganesan V, Aeromonas. An unusual cause of lower gastrointestinal bleed. Indian J Med Microbiol. 2016;34:395–6. [DOI: 10.4103/0255-0857.188375]
  15. Epidemiological Surveillance System. Epidemiological comment on reported diseases and Microbiological Information System, Spain. Boletín Epidemiol Semanal. 2007;15:109–14.
  16. Ko WC, Chuang YC. Aeromonas bacteremia: review of 59 episodes. Clin Infect Dis. 1995;20:1298–304. [DOI: 10.1093/clinids/20.5.1298]
  17. Veeren G, Haripriya Reddy C, Nandini S, Vishnu Rao P, Ramasubramanian V, Senthur Nambi P, Gopalakrishnan R. Infections caused by Aeromonas species in hospitalized patients: a case series. Indian J Med Microbiol. 2022;40:306–8. [DOI: 10.1016/j.ijmmb.2022.01.006]
  18. Nolla-Salas J, Codina-Calero J, Valles-Angulo S, Sitges-Serra A, Zapatero-Ferrandiz A, Climent MC, Gomez J, Masclans JR. Clinical significance and outcome of Aeromonas spp. infections among 204 adult patients. Eur J Clin Microbiol Infect Dis. 2017;36:1393–403. [DOI: 10.1007/s10096-017-2945-4]
  19. Chao CM, Lai CC, Tang HJ, Ko WC, Hsueh PR. Biliary tract infections caused by Aeromonas species. Eur J Clin Microbiol Infect Dis. 2013;32:245–51. [DOI: 10.1007/s10096-012-1736-1]
  20. Rhee JY, Jung DS, Peck KR. Clinical and therapeutic implications of Aeromonas Bacteremia: 14 years nation-wide experiences in Korea. Infect Chemother. 2016;48:274–84. [DOI: 10.3947/ic.2016.48.4.274]
  21. Lay CJ, Zhuang HJ, Ho YH, Tsai YS, Wang LS, Tsai CC. Different clinical characteristics between polymicrobial and monomicrobial Aeromonas bacteremia–a study of 216 cases. Intern Med. 2010;49:2415–21. [DOI: 10.2169/internalmedicine.49.4117]
  22. Fraisse T, Lechiche C, Sotto A, Lavigne JP. [Aeromonas spp. infections: retrospective study in Nimes University Hospital, 1997–2004]. Pathol Biol (Paris). 2008;56:70–6. [DOI: 10.1016/j.patbio.2007.12.002]
  23. Gold WL, Salit IE. Aeromonas hydrophila infections of skin and soft tissue: report of 11 cases and review. Clin Infect Dis. 1993;16:69–74. [DOI: 10.1093/clinids/16.1.69]
  24. Tang HJ, Lai CC, Lin HL, Chao CM. Clinical manifestations of bacteremia caused by Aeromonas species in southern Taiwan. PLoS ONE. 2014;9:e91642. [DOI: 10.1371/journal.pone.0091642]
  25. Vally H, Whittle A, Cameron S, Dowse GK, Watson T. Outbreak of Aeromonas hydrophila wound infections associated with mud football. Clin Infect Dis. 2004;38:1084–9. [DOI: 10.1086/382876]
  26. Vila J, Marco F, Soler L, Chacon M, Figueras MJ. In vitro antimicrobial susceptibility of clinical isolates of Aeromonas caviae, Aeromonas hydrophila and Aeromonas veronii biotype sobria. J Antimicrob Chemother. 2002;49:701–2. [DOI: 10.1093/jac/49.4.701]
  27. Han JE, Kim JH, Cheresca CH Jr., Shin SP, Jun JW, Chai JY, Han SY, Park SC. First description of the qnrs-like (qnrS5) gene and analysis of quinolone resistance-determining regions in motile Aeromonas spp. from diseased fish and water. Res Microbiol. 2012;163:73–9. [DOI: 10.1016/j.resmic.2011.09.001]

MeSH Term

Male
Humans
Female
Aeromonas hydrophila
Retrospective Studies
Tertiary Care Centers
Saudi Arabia
Anti-Bacterial Agents
Aeromonas

Chemicals

Anti-Bacterial Agents

Word Cloud

Created with Highcharts 10.0.0AeromonasSaudiArabiainfections30-daymortalityp < 0hydrophilainfection3%commonpatientsstudyculturescomorbiditiessusceptibilitynumberrangediseasesfactorsclinicalpresentationtreatmentretrospectivetertiaryuniversityhospital1cultureresults835%3comorbidityratio05bestpredictivevalueBACKGROUND:cancausewidemainlyfoundunderlyingGloballydatalimitedstudiespublishedsituationaiminvestigateriskoutcomesMETHODS:performed1000bedsJeddah14yearsolderAeromonas-positiveJanuary2015December312022includedPatientinformationextractedelectronichealthrecordsincludingpatientdemographicspresentingsymptomssourcehumanimmunodeficiencyvirusstatusantimicrobialuseimmunosuppressivemedicationRESULTS:total24identifiedhydrophila-positive22males917%75%hospital-acquired208%susceptiblegentamicincefepimeciprofloxacinmajorityresistantceftazidimemeropenem62diseaseskinsofttissue33signfever58symptomabdominalpain37Comorbiditiesmedian1-7Pittbacteremiascore001Charlsonweightedindex02internationalnormalized005associateddueOdds25395%confidenceinterval:088-9729CONCLUSIONS:importantpathogenconsidernosocomialpatternorganismindicatessuspectedquinolonealongbroad-spectrumantibioticsstartedknownComorbidityMortalityNosocomialRetrospectiveSusceptibility

Similar Articles

Cited By